In contrast, 4/8 patients did not use G-CSF at the first neutropenia episode and stopped clozapine for an average time of 16 months before a rechallenge was attempted, which is longer than the 9 months median time reported by Myles and colleagues’ (Myles et al., 2017). This evidence concerns the gene CSF3 and neutropenia.